Finland· FI-REL-REL703
Locacorten-Vioform
A flumetason und antiinfektiva product containing flumetasone pivalate + clioquinol, registered in Finland by Amdipharm Limited. The same ATC class is registered in 4 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Flumetason und antiinfektiva is registered in 4 of 19 countries.
Countries holding a registration under ATC S02CA02 (flumetason und antiinfektiva), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Flumetason und antiinfektiva · ATC S02CA02
4 / 19 countries
- Canada
- Denmark
- Finlandprice
- Netherlands
The record
At a glance
Fimea (Finland)- Active substance
- Flumetasone pivalate + Clioquinol
- Manufacturer
- Amdipharm Limited
- Country
- Finland (FI)
- ATC code
- S02CA02
- ATC class
- Flumetason und Antiinfektiva
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Flumetason und antiinfektiva in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFlumetasone 0.02% / Clioquinol 1% ear dropsDE Pharmaceuticals
- CanadaLOCACORTEN VIOFORMENDO OPERATIONS LTD.
- GermanyLocacorten-VioformEsteve Pharmaceuticals Gmbh
- SwedenLocacorten-Vioform 0,2 mg/ml + 10 mg/ml Örondroppar, lösningAmdipharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Bulgaria · Лоринден C
- Germany · Locacorten-Vioform
- Denmark · Locacorten - Vioform
- United Kingdom (Northern Ireland) · Flumetasone/Clioquinol Amdipharma Uk Limited, Locorten Vioform
- Lithuania · Lorinden C
- Latvia · Lorinden C
- Netherlands · Locacorten-Vioform
- Poland · Lorinden C
- Sweden · Locacorten-Vioform
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db9b30fb-703f-42ee-aa44-3fbc89783a71 GET /v1/drugs/db9b30fb-703f-42ee-aa44-3fbc89783a71?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "korvatipat, liuos",
"route": "Korvaan",
"ddd_unit": null,
"strength": "0.2 mg/ml + 10 mg/ml",
"atc_label": "flumetasoni ja mikrobilääkkeet",
"ma_number": "5753",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL703",
"authorised_at": "1969-04-30"
}See everything about flumetason und antiinfektiva.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.